Home › Funds › EMERALD ADVISERS, LLC › COGT

EMERALD ADVISERS, LLC position in COGT

COGENT BIOSCIENCES INC · Health Care

EMERALD ADVISERS, LLC reported holding 1,613,541 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$51.7M, representing 1.42% of its reported portfolio and ranking #12 among its reported holdings. EMERALD ADVISERS, LLC has disclosed COGT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.61M sh
Reported value held$51.67M
Portfolio Weight1.42%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EMERALD ADVISERS, LLC's COGT position evolved

EMERALD ADVISERS, LLC first disclosed a stake in COGT in Q2 2025 at 1,445,774 shares (US$10.4M). The position peaked in Q2 2026 at 1,603,319 shares, worth US$62.0M. Across 6 filings, EMERALD ADVISERS, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,613,541 shares valued at US$51.7M — an increase of 10,222 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.45M $10.38M New
Q3 2025 1.58M $22.68M Add
Q4 2025 1.58M $56.24M Hold
Q1 2026 1.59M $61.13M Hold
Q2 2026 1.60M $62.05M Add
Q3 2026 1.61M $51.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 55 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has EMERALD ADVISERS, LLC held COGT?

EMERALD ADVISERS, LLC has disclosed COGT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is EMERALD ADVISERS, LLC's current position in COGT?

As of Q3 2026, EMERALD ADVISERS, LLC holds 1.61M shares of COGT (COGENT BIOSCIENCES INC), valued at $51.67M, representing 1.42% of its reported portfolio and ranking #12.

Has EMERALD ADVISERS, LLC been buying or selling COGT?

In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC increased its position in COGT. The position peaked in Q2 2026 at 1.60M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.